• Bookmark and Share

Johnson & Johnson to Receive Hope Award for Outstanding Corporate Partnership

Last Updated on Wednesday, November 02, 2011

Award Recognizes Company’s Longstanding Commitment to Preeclampsia Foundation’s Mission

New York, NY - November 02, 2011
- The Preeclampsia Foundation announced today that Johnson & Johnson is the recipient of its 2011 Hope Award for Outstanding Corporate Partnership, recognizing the significant contribution the company has made to the field of preeclampsia research, education and awareness through a productive collaboration with the Preeclampsia Foundation.

The award will be presented to Roy Davis, President of Johnson & Johnson Development Corporation at the Foundation’s annual benefit gala, Saving Grace – A Night of Hope and Gratitude, held this year on Saturday, November 12, at the Hilton New York in New York City, New York. Davis has been instrumental in enabling the company’s support, providing strategic advice, industry contacts and encouraging employee support of the Foundation’s mission, as well as securing the ongoing financial support that has enabled the Preeclampsia Foundation to advance its research and education programs. “I have a deep commitment to doing something about this disease,” said Davis, who is happy to assist Johnson & Johnson’s plans for maternal-infant health and well-being.

“Roy personally represents the innovation and forward vision that we need.” explained Eleni Tsigas, executive director of the Preeclampsia Foundation. “He brings a personal and infectious passion for our cause, inspiring not only his fellow employees but other industry leaders to make a difference for this critical issue in maternal and infant health. Our research and education projects have made remarkable progress, in large part due to Johnson & Johnson’s support.”

The maternal and child health initiatives of Johnson & Johnson were also recently recognized with the UN 2011 Humanitarian of the Year Award, which was given for the Company’s leading role in support of the UN’s Every Woman Every Child initiative. This effort aims to meet the UN Millennium Development Goals in women and children’s health in the developing world.

“During its 125 year history, Johnson & Johnson has supported initiatives that strive to meet healthcare needs and improve the lives of people worldwide,” the company said in a statement. “The Preeclampsia Foundation shares this passion. We are proud to support their commitment to improving the lives of families worldwide.”

More information about Saving Grace – A Night of Hope & Gratitude, the dinner gala where the award will be presented, can be found at http://www.savinggrace.preeclampsia.org.

About the Preeclampsia Foundation: The Preeclampsia Foundation is a U.S.-based 501(c)(3) not-for-profit organization established in 2000. It is dedicated to providing patient support and education, raising public awareness, catalyzing research and improving health care practices, envisioning a world where preeclampsia and related hypertensive disorders of pregnancy no longer threaten the lives of mothers and babies. For more information, visit http://www.preeclampsia.org.


We’ll be Speaking Here

2016 ACOG-CDC Meeting on Maternal Safety and Mortality
Washington DC

May 15, 2016 


Healthy Start Coalition of Miami-Dade Prematurity Symposium
Miami, FL

May 20, 2016



11th Annual Texas Conference on Health Disparities
Ft. Worth, TX

June 9-10, 2016


Invite Us to Speak at Your Event


Preeclampsia in the News

Featured Video

What’s Happening on Twitter

Preeclampsia Are you the #faceofpreeclampsia? Share your story at https://t.co/gwhj1dOoGd. Any woman. Any pregnancy. #PreAM16
Preeclampsia 500,000 babies die worldwide each year because of preeclampsia, due to preterm labor, placental abruption & other complications. #PreAM16
Preeclampsia When we talk about the emotional impact of preeclampsia, it's important to remember that it's not just moms and... https://t.co/WG0hgfiWvJ

Press Releases by Year

Other Resources

JOIN OUR MAILING LIST. We respect your privacy.